Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization

International Journal of Cancer

Volumn 74, Issue 6, 1997, Pages 588-592

  Okami, Kenji ^a,c   Cairns, Paul ^a   Westra, William H ^b   Linn, Jurgen F ^a   Ahrendt, Steven A ^b   Wu, Li ^a   Sidransky, David ^a   Jen, Jin ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 9P; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; FROZEN SECTIONS; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MICROSATELLITE REPEATS;

EID: 0031442680     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971219)74:6<588::AID-IJC5>3.0.CO;2-Q     Document Type: Article

References (23)

1. CAIRNS, P., MAO, L., MERLO, A., LEE D.J., SCHWAB, D., EBY, Y., TOKINO, K., VAN DER RIET, P., BLAUGRUND, J.E., and SIDRANSKY, D., Rates of p16 (MTSI) mutations in primary tumors with 9p loss. Science 265, 415-417 (1994).
2. CAIRNS, P. and 20 OTHERS, Frequency of homozygous deletion at p16/ CDKN2 in primary human tumours. Nature (Genet.), 11, 210-212 (1995).
3. CALIFANO, J., VAN DER RIET, P., WESTRA, W., NAWROZ, H., CLAYMAN, G., PIANTADOSI, S., CORIO, R., LEE, D., GREENBERG, B., KOCH, W., and SIDRANSKY, D., Genetic progression model for head and neck cancer: implication for field cancerization. Cancer Res., 56, 2488-2492 (1946).
4. DREYLING, M.H., BOHLANDER, S.K., ADEYANJU, M.O., and OLOPADE, O.I., Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res., 55, 984-988 (1995).
5. DROPCHO, E.J., and KING, P.H., Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies. Ann. Neurol., 36, 200-205 (1994).
6. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S.I., JOHNSON, B.E., and SKOLNICK, M.H., A cell cycle regulator potentially involved in the genesis of many tumor types. Science, 264, 436-440 (1994).
7. KIM, S.K., RO, J.Y., KEMP, B.L., LEE, J.S., KWON, T.J., FONG, K.M., SEKIDO, Y., MINNA, J.D., HONG, W.K., and MAO, L., Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer. Cancer Res., 57, 400-403 (1997).
8. KING, P.H., and DROPCHO, E.J., Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma. Ann. Neurol., 39, 679-681 (1996).
9. LENGAUER, C., HENN, T., ONYANGO, P., FRANCIS, F., LEHRACH, H., and WEITH, A., Large-scale isolation of human 1p36-specific P1 clones and their use for fluorescence in situ hybridization. Gen. Anal. Techn. Appl., 11, 140-147 (1994).
10. LICHTER, P., and CREMER, T., Chromosome analysis by non-isotopic in situ hybridization. In: D.E. Rooney and B.W. Czepulkowski (eds.), Human cytogenetics, vol I: a practical approach, (2nd ed.), pp. 157-192, IRL, Oxford (1992).
11. MATSUTA, M., MATSUTA, M., SASAKI, K., HARIU, H., NISHTYA, I., KATOU, M., KALLIONIEMI, A., WEIER, H.U., and GRAY, J.W., Application of confocal laser scanning microscope on fluorescence in situ hybridisation (FISH). Acta Histochem. Cytochem., 26, 415-121 (1993).
12. MERLO, A., GABRIELSON, E., ASKIN, F., and SIDRANSKY, D., Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res., 54, 640-642 (1994).
13. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GARRIBESON, E., BURGER, P.C., BAYLIN, S.B., and SIDRANSKY, D., 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTS1 in human cancers. Nature (Med)., 1, 686-692 (1995).
14. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K., and CARSON, D.A., Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
15. OLOPADE, O., POMYLKALA, H., HAGOS, F., SVEEN, L.W., ESPINOSA, R., III. DREYLING, M.H., GURSKY, S., STADLER, W.M., LE BEAU, M.M., and BOHLANDER, S.K., Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorslase gene from the tumor suppressor region on 9p21. Proc. Natl. Acad. Sci. (Wash.). 92, 6489-6493 (1995).
16. OLOPADE, O.I., BUCHHAGEN, D.L., MALIK, K., SHERMAN, J., NOBORI, T., NAU, M.M., GAZDAR, A.F., MINNA, J.D., and DIAZ, M.O., Homozygous loss of interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res., 53 (Suppl. 10), 2410-2415 (1993).
17. REED, A.L., CALIFANO, J., CAIRNS, P., WESTRA, W.H., JONES, R.M., KOCH, W., AHRENDT, S., EBY, Y., SEWELL, D., NAWROZ, H., BARTEK, J., and SIDRANSKY, D., High frequency of p16 (CDKN2/MTS-1/1NK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56, 3630-3633 (1996).
18. SIDRANSKY, D., Importance of chromosome 9p loss in human lung cancer [editorial: comment]. J. Natl. Cancer Inst., 87, 1201-1202 (1995).
19. THOMPSON, C., LEBOIT, P.E., NEDERLOF, P.M., and GRAY, J.W., Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. Amer. J. Pathol., 144, 237-243 (1994).
20. VAN DER RIET, P., NAWROZ, H., HRUBAN, R.H., CORIO, R., TOKINO, K., KOCH, W., and SIDRANSKY, D., Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res., 54, 1156-8 (1994).
21. Vos, S., MILLER, C., TAKEUCHI, S., GOMBART, A., CHO, S., and KOEFFLER, H., Alteration of CDKN2 (p16) in non-small cell lung cancer. Genes Chromosomes Cancer, 14, 164-170 (1995).
22. WEAVER-FELDHAUS, J., GRUIS, N.A., NEUHAUSEN, S., LE PASLIER, D., STOCKERT, E., SKOLNICK, M.H., and KAMB, A., Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc. Natl. Acad. Sci. (Wash.), 91, 7563-7567 (1994).
23. WIEST, J.S. and 12 OTHERS, Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res., 57, 1-6 (1997).